Which laboratory tests are commonly considered in evaluating nausea and vomiting?

Study for ELNEC 4: Symptom Management in Palliative Care Test with flashcards and multiple choice questions. Hints and explanations included! Get ready for your exam!

Multiple Choice

Which laboratory tests are commonly considered in evaluating nausea and vomiting?

Evaluating nausea and vomiting involves checking for reversible metabolic problems, organ dysfunction, and potential structural or neurologic causes. The most useful test set in this context includes renal and liver function tests to detect kidney or liver disease that can provoke or worsen symptoms, along with electrolytes to identify dehydration, acid-base disturbances, and electrolyte imbalances common with vomiting. Calcium is included because abnormalities can contribute to GI symptoms or indicate an underlying endocrine or oncologic process. Measuring serum drug levels helps reveal toxicity from medications frequently implicated in nausea in palliative care, such as opioids, antibiotics, or chemotherapeutic agents. Abdominal imaging with x-rays can uncover bowel obstruction, ileus, or other intraluminal issues, while head imaging with a CT or MRI screens for intracranial problems like masses, hemorrhage, or increased intracranial pressure that can present with vomiting, especially if neurologic signs or headache are present. Other options are too narrow to capture the full differential. A CBC with differential and inflammatory markers can hint at infection or inflammation but doesn’t directly address metabolic or structural causes. A lipid panel or serum amylase alone focuses on specific conditions (lipid disorders or pancreatic involvement) and misses the broader range of etiologies that commonly present with nausea and vomiting. The broad, integrative approach in this set best guides further targeted testing and management.

Evaluating nausea and vomiting involves checking for reversible metabolic problems, organ dysfunction, and potential structural or neurologic causes. The most useful test set in this context includes renal and liver function tests to detect kidney or liver disease that can provoke or worsen symptoms, along with electrolytes to identify dehydration, acid-base disturbances, and electrolyte imbalances common with vomiting. Calcium is included because abnormalities can contribute to GI symptoms or indicate an underlying endocrine or oncologic process. Measuring serum drug levels helps reveal toxicity from medications frequently implicated in nausea in palliative care, such as opioids, antibiotics, or chemotherapeutic agents. Abdominal imaging with x-rays can uncover bowel obstruction, ileus, or other intraluminal issues, while head imaging with a CT or MRI screens for intracranial problems like masses, hemorrhage, or increased intracranial pressure that can present with vomiting, especially if neurologic signs or headache are present.

Other options are too narrow to capture the full differential. A CBC with differential and inflammatory markers can hint at infection or inflammation but doesn’t directly address metabolic or structural causes. A lipid panel or serum amylase alone focuses on specific conditions (lipid disorders or pancreatic involvement) and misses the broader range of etiologies that commonly present with nausea and vomiting. The broad, integrative approach in this set best guides further targeted testing and management.

More practice questions